Lista de obras - Agnieszka Czarniecka - Dominio Público Uruguay

Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma.

artículo científico publicado en 2017

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

artículo científico publicado en 2013

Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.

artículo científico publicado en 2014

BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer

artículo científico publicado en 2018

BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer

artículo científico publicado en 2021

BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma

scientific article published on 29 November 2019

BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma

artículo científico publicado en 2015

Childhood thyroid carcinoma — single-centre experience

artículo científico publicado en 2021

Coexistence of Promoter Mutations and the V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients

artículo científico publicado en 2018

Corrigendum: Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations

artículo científico publicado en 2017

Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses? ⬇️

artículo científico publicado en 2017

Current status of the prognostic molecular markers in medullary thyroid carcinoma

artículo científico publicado en 2020

Current surgical management in RET mutation carriers [Aktualne postępowanie chirurgiczne u nosicieli mutacji proto-onkogenu RET].

artículo científico publicado en 2019

Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych — Rekomendacje Polskich Tow

artículo científico publicado en 2022

Diagnostics and Treatment of Thyroid Carcinoma

artículo científico publicado en 2016

Diagnostics and treatment of differentiated thyroid carcinoma in children - Guidelines of Polish National Societies.

artículo científico publicado en 2016

Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist? ⬇️

artículo científico publicado en 2020

Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations.

artículo científico publicado en 2017

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

artículo científico publicado en 2015

European perspective on the use of molecular tests in the diagnosis and therapy of thyroid neoplasms

scientific article published on 01 February 2020

Evaluation of the therapeutic benefits in relation to the extent of surgery in patients with differentiated thyroid carcinoma

artículo científico publicado en 2006

Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours

artículo científico publicado en 2017

Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications

scientific article published on 01 February 2005

Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update

artículo científico publicado en 2018

Heterogeneity of Thyroid Cancer

artículo científico publicado en 2018

Impact of the Tumor Microenvironment on the Gene Expression Profile in Papillary Thyroid Cancer

scientific article published on 22 April 2020

Laparoscopic cortical sparing adrenal surgery in pheochromocytomas associated with hereditary neoplasia syndromes

artículo científico publicado en 2020

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015.

artículo científico publicado en 2017

Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues.

artículo científico publicado en 2013

Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions

artículo científico publicado en 2010

Novel TG-FGFR1 and TRIM33-NTRK1 transcript fusions in papillary thyroid carcinoma

artículo científico publicado en 2019

Occurrence of BRAF mutations in a Polish cohort of PTC patients - preliminary results.

artículo científico publicado en 2010

Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.

artículo científico publicado en 2016

Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer.

artículo científico publicado en 2017

Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma

scientific article published on 05 September 2019

Prognostic value of lymph node metastases of differentiated thyroid cancer (DTC) according to the local advancement and range of surgical excision

artículo científico publicado en 2010

Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy

artículo científico publicado en 2017

Somatic mutation profiling of follicular thyroid cancer by next generation sequencing

artículo científico publicado en 2016

Surgical approach to differentiated thyroid cancers (DTC) in children [Specyfika leczenia chirurgicznego zróżnicowanych raków tarczycy (ZRT) u dzieci]

scientific article published on 01 January 2019

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma

scientific article published on 17 June 2020

The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer

artículo científico publicado en 2017

The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors

artículo científico publicado en 2015

The impact of the extent and time of operation on the survival in patients with differentiated thyroid carcinoma (DTC)

artículo científico publicado en 2006

The prevalence of somatic RAS mutations in medullary thyroid cancer - a Polish population study

artículo científico publicado en 2015

Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma - Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015

artículo científico publicado en 2021

Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers - the role of Ct serum level

artículo científico

Unsupervised analysis of follicular thyroid tumours transcriptome by oligonucleotide microarray gene expression profiling

artículo científico publicado en 2013

[Completion total thyroidectomy in children with differentiated thyroid cancer]

artículo científico publicado en 2006

[Diagnosis and treatment of thyroid cancer - Polish guidelines].

artículo científico publicado en 2010

[Gene expression analysis by DNA microarray in papillary thyroid cancer]

artículo científico publicado en 2005

[Indications for surgery of thyroid cancer based on bioptate molecular examination].

artículo científico publicado en 2006

Lista de obras de Agnieszka Czarniecka

Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma.

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.

BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer

BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer

BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma

BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma

Childhood thyroid carcinoma — single-centre experience

Coexistence of Promoter Mutations and the V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients

Corrigendum: Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations

Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses? ⬇️

Current status of the prognostic molecular markers in medullary thyroid carcinoma

Current surgical management in RET mutation carriers [Aktualne postępowanie chirurgiczne u nosicieli mutacji proto-onkogenu RET].

Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych — Rekomendacje Polskich Tow

Diagnostics and Treatment of Thyroid Carcinoma

Diagnostics and treatment of differentiated thyroid carcinoma in children - Guidelines of Polish National Societies.

Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist? ⬇️

Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations.

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

European perspective on the use of molecular tests in the diagnosis and therapy of thyroid neoplasms

Evaluation of the therapeutic benefits in relation to the extent of surgery in patients with differentiated thyroid carcinoma

Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours

Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications

Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update

Heterogeneity of Thyroid Cancer

Impact of the Tumor Microenvironment on the Gene Expression Profile in Papillary Thyroid Cancer

Laparoscopic cortical sparing adrenal surgery in pheochromocytomas associated with hereditary neoplasia syndromes

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015.

Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues.

Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions

Novel TG-FGFR1 and TRIM33-NTRK1 transcript fusions in papillary thyroid carcinoma

Occurrence of BRAF mutations in a Polish cohort of PTC patients - preliminary results.

Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.

Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer.

Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma

Prognostic value of lymph node metastases of differentiated thyroid cancer (DTC) according to the local advancement and range of surgical excision

Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy

Somatic mutation profiling of follicular thyroid cancer by next generation sequencing

Surgical approach to differentiated thyroid cancers (DTC) in children [Specyfika leczenia chirurgicznego zróżnicowanych raków tarczycy (ZRT) u dzieci]

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma

The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer

The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors

The impact of the extent and time of operation on the survival in patients with differentiated thyroid carcinoma (DTC)

The prevalence of somatic RAS mutations in medullary thyroid cancer - a Polish population study

Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma - Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015

Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers - the role of Ct serum level

Unsupervised analysis of follicular thyroid tumours transcriptome by oligonucleotide microarray gene expression profiling

[Completion total thyroidectomy in children with differentiated thyroid cancer]

[Diagnosis and treatment of thyroid cancer - Polish guidelines].

[Gene expression analysis by DNA microarray in papillary thyroid cancer]

[Indications for surgery of thyroid cancer based on bioptate molecular examination].